Source: FinSMEs

Tergus: MedPharm and Tergus Pharma Merge

MedPharm, a Guildford, UK-based topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announced a merger with Tergus Pharma, a Research Triangle Park, NC-based end-to-end contract service provider and a Great Point Partners portfolio company. The combined organization will operate under the MedPharm name, establishing an end-to-end CDMO with scientific, [...]The post MedPharm and Tergus Pharma Merge appeared first on FinSMEs.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Michael Kane's photo - CEO of Tergus

CEO

Michael Kane

CEO Approval Rating

82/100

Read more